Cargando…

Regulation of Th2 responses by different cell types expressing the interleukin-31 receptor

BACKGROUND: Interleukin-31 (IL-31) is a recently identified cytokine produced by Th2 cells that is involved in the development of atopic dermatitis-induced skin inflammation and pruritus. Its receptor, IL-31RA, is expressed by a number of cell types, including epithelial cells, eosinophils, and acti...

Descripción completa

Detalles Bibliográficos
Autores principales: Saito, Saburo, Aoki, Ayana, Arai, Iwao, Takaishi, Shinya, Ito, Haruyasu, Akiyama, Nobutake, Kiyonari, Hiroshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5392993/
https://www.ncbi.nlm.nih.gov/pubmed/28428802
http://dx.doi.org/10.1186/s13223-017-0194-9
_version_ 1783229509677350912
author Saito, Saburo
Aoki, Ayana
Arai, Iwao
Takaishi, Shinya
Ito, Haruyasu
Akiyama, Nobutake
Kiyonari, Hiroshi
author_facet Saito, Saburo
Aoki, Ayana
Arai, Iwao
Takaishi, Shinya
Ito, Haruyasu
Akiyama, Nobutake
Kiyonari, Hiroshi
author_sort Saito, Saburo
collection PubMed
description BACKGROUND: Interleukin-31 (IL-31) is a recently identified cytokine produced by Th2 cells that is involved in the development of atopic dermatitis-induced skin inflammation and pruritus. Its receptor, IL-31RA, is expressed by a number of cell types, including epithelial cells, eosinophils, and activated monocytes and macrophages. To date, however, the regulation of Th2 responses by distinct cell types and tissues expressing IL-31RA has not been well studied. METHODS: In this study, Cry j 2, one of the major allergens of Japanese cedar pollen, was administered to IL-31RA-deficient or wild-type (WT) mice via nasal or intraperitoneal injection for induction of specific Th2 responses. RESULTS: After nasal administration of Cry j 2, IL-31RA-deficient mice showed lower Cry j 2-specific CD4+ T cell proliferation, Th2 cytokine (IL-5 and IL-13) production, and Th2-mediated (IgE, IgG1, and IgG2b) antibody responses than WT mice. In contrast, IL-31RA-deficient mice administered Cry j 2 intraperitoneally showed stronger Th2 immune responses than WT mice. CONCLUSIONS: These results indicate that IL-31R signaling positively regulates Th2 responses induced by nasal administration of Cry j 2, but negatively regulates these responses when Cry j 2 is administered intraperitoneally. Collectively, these data indicate that the induction of antigen-specific Th2 immune responses might depend on tissue-specific cell types expressing IL-31RA.
format Online
Article
Text
id pubmed-5392993
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-53929932017-04-20 Regulation of Th2 responses by different cell types expressing the interleukin-31 receptor Saito, Saburo Aoki, Ayana Arai, Iwao Takaishi, Shinya Ito, Haruyasu Akiyama, Nobutake Kiyonari, Hiroshi Allergy Asthma Clin Immunol Research BACKGROUND: Interleukin-31 (IL-31) is a recently identified cytokine produced by Th2 cells that is involved in the development of atopic dermatitis-induced skin inflammation and pruritus. Its receptor, IL-31RA, is expressed by a number of cell types, including epithelial cells, eosinophils, and activated monocytes and macrophages. To date, however, the regulation of Th2 responses by distinct cell types and tissues expressing IL-31RA has not been well studied. METHODS: In this study, Cry j 2, one of the major allergens of Japanese cedar pollen, was administered to IL-31RA-deficient or wild-type (WT) mice via nasal or intraperitoneal injection for induction of specific Th2 responses. RESULTS: After nasal administration of Cry j 2, IL-31RA-deficient mice showed lower Cry j 2-specific CD4+ T cell proliferation, Th2 cytokine (IL-5 and IL-13) production, and Th2-mediated (IgE, IgG1, and IgG2b) antibody responses than WT mice. In contrast, IL-31RA-deficient mice administered Cry j 2 intraperitoneally showed stronger Th2 immune responses than WT mice. CONCLUSIONS: These results indicate that IL-31R signaling positively regulates Th2 responses induced by nasal administration of Cry j 2, but negatively regulates these responses when Cry j 2 is administered intraperitoneally. Collectively, these data indicate that the induction of antigen-specific Th2 immune responses might depend on tissue-specific cell types expressing IL-31RA. BioMed Central 2017-04-17 /pmc/articles/PMC5392993/ /pubmed/28428802 http://dx.doi.org/10.1186/s13223-017-0194-9 Text en © The Author(s) 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Saito, Saburo
Aoki, Ayana
Arai, Iwao
Takaishi, Shinya
Ito, Haruyasu
Akiyama, Nobutake
Kiyonari, Hiroshi
Regulation of Th2 responses by different cell types expressing the interleukin-31 receptor
title Regulation of Th2 responses by different cell types expressing the interleukin-31 receptor
title_full Regulation of Th2 responses by different cell types expressing the interleukin-31 receptor
title_fullStr Regulation of Th2 responses by different cell types expressing the interleukin-31 receptor
title_full_unstemmed Regulation of Th2 responses by different cell types expressing the interleukin-31 receptor
title_short Regulation of Th2 responses by different cell types expressing the interleukin-31 receptor
title_sort regulation of th2 responses by different cell types expressing the interleukin-31 receptor
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5392993/
https://www.ncbi.nlm.nih.gov/pubmed/28428802
http://dx.doi.org/10.1186/s13223-017-0194-9
work_keys_str_mv AT saitosaburo regulationofth2responsesbydifferentcelltypesexpressingtheinterleukin31receptor
AT aokiayana regulationofth2responsesbydifferentcelltypesexpressingtheinterleukin31receptor
AT araiiwao regulationofth2responsesbydifferentcelltypesexpressingtheinterleukin31receptor
AT takaishishinya regulationofth2responsesbydifferentcelltypesexpressingtheinterleukin31receptor
AT itoharuyasu regulationofth2responsesbydifferentcelltypesexpressingtheinterleukin31receptor
AT akiyamanobutake regulationofth2responsesbydifferentcelltypesexpressingtheinterleukin31receptor
AT kiyonarihiroshi regulationofth2responsesbydifferentcelltypesexpressingtheinterleukin31receptor